Biomarkers in spinal muscular atrophy
Spinal muscular atrophy is a hereditary disorder leading to severe neuromuscular impairment. With the introduction of disease-modifying therapies in recent years, the role of biomarkers has expanded from aiding diagnosis to monitoring treatment responses, prognostic assessment, and the development o...
Saved in:
| Main Authors: | Liping Yan, Jinping Zhang, Jian Zheng, Hua Hao |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-07-01
|
| Series: | Frontiers in Neurology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fneur.2025.1636992/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Outcomes of genetic testing and prenatal diagnosis of spinal muscular atrophy in Jordan
by: Mohammad Shboul, et al.
Published: (2025-12-01) -
Factors modifying the course of spinal muscular atrophy 5q
by: M. A. Akhkiamova, et al.
Published: (2024-01-01) -
Approaches to pathogenetic therapy of spinal muscular atrophy in children and newborns
by: S. B. Artemyeva, et al.
Published: (2024-03-01) -
Molecular-genetic study of <i>SMN1</i> and <i>SMN2</i> genes associated with spinal muscular atrophy in individuals with infertility prior to in vitro fertilization
by: E. V. Kudryavtseva, et al.
Published: (2024-01-01) -
Long‐Term Effects of Nusinersen Dosing Frequency on Adult Patients With Spinal Muscular Atrophy: Efficacy of a 6‐Month Dosing Interval
by: Keita Takahashi, et al.
Published: (2025-05-01)